Non-calcium-based phosphate binders in CKD-MBD are preferred to prevent which complication?

• A. Hypophosphatemia
• B. Hypercalcemia
• C. Hypercalciuria
• D. Hypercalcemia and vascular calcification

Answer: (D)

The key concept here is managing phosphate in CKD without adding extra calcium. In CKD–MBD, phosphate tends to rise and binding it in the gut helps prevent its absorption, but using calcium-based binders can raise serum calcium. That extra calcium can combine with phosphate to increase the calcium–phosphate product, promoting deposition of calcium in blood vessels (vascular calcification) and worsening cardiovascular risk. Non-calcium–based phosphate binders bind phosphate in the gut without delivering calcium, so they lower phosphate while staying neutral on calcium load. This reduces the likelihood of hypercalcemia and the downstream vascular calcification that hypercalcemia promotes. So these binders are preferred to prevent those complications.